BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11078825)

  • 1. Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus.
    Noguchi K; Nakashima O; Nakashima Y; Shiota K; Nawata H; Kojiro M
    Int J Mol Med; 2000 Dec; 6(6):661-5. PubMed ID: 11078825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
    Hashimoto M; Tashiro H; Kobayashi T; Kuroda S; Hamaoka M; Ohdan H
    Int J Surg; 2017 Mar; 39():206-213. PubMed ID: 28159713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.
    Yamashita Y; Imai D; Bekki Y; Kimura K; Matsumoto Y; Nakagawara H; Ikegami T; Yoshizumi T; Shirabe K; Aishima S; Maehara Y
    Ann Surg Oncol; 2015 Jul; 22(7):2279-85. PubMed ID: 25472646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy.
    Takeishi K; Maeda T; Shirabe K; Tsujita E; Yamashita Y; Harimoto N; Itoh S; Ikegami T; Yoshizumi T; Maehara Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1116-24. PubMed ID: 26159442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma.
    Yamanaka N; Tanaka T; Tanaka W; Yamanaka J; Yasui C; Kuroda N; Takada M; Okamoto E
    Cancer; 1997 Apr; 79(8):1509-15. PubMed ID: 9118031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery.
    Kondo K; Chijiiwa K; Funagayama M; Kai M; Otani K; Ohuchida J
    J Gastrointest Surg; 2008 Mar; 12(3):468-76. PubMed ID: 17999119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.
    Shiratori Y; Shiina S; Imamura M; Kato N; Kanai F; Okudaira T; Teratani T; Tohgo G; Toda N; Ohashi M
    Hepatology; 1995 Oct; 22(4 Pt 1):1027-33. PubMed ID: 7557847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.
    Nakamoto N; Saito H; Ebinuma H; Tada S; Saito Y; Kurita S; Kitamura K; Ishii H
    Intern Med; 2003 Apr; 42(4):322-30. PubMed ID: 12729320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcome in cirrhotic patients with hepatitis C-related hepatocellular carcinoma.
    Hanazaki K; Wakabayashi M; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Kawamura N; Miyazaki T
    Hepatogastroenterology; 2000; 47(31):204-10. PubMed ID: 10690610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.